公开(公告)号：US20170209522A1

公开(公告)日：2017-07-27

申请号：US15322779

申请日：2015-06-30

Applicant: ROHTO PHARMACEUTICAL CO., LTD.

Inventor： Masatoshi Haga ,  Keiko Oyamada ,  Rumi Matsushita ,  Yuya Hayashi ,  Kyoko Nakajima ,  Yuko Kouda

IPC: A61K38/05 ,  A61K8/67 ,  A61K8/34 ,  A61Q19/08 ,  A61K47/10 ,  A61Q11/00 ,  A61K31/045 ,  A61K31/375 ,  A61K9/00 ,  A61K45/06 ,  A61K8/64 ,  A61Q15/00

CPC classification number: A61K38/05 ,  A61K8/34 ,  A61K8/44 ,  A61K8/4946 ,  A61K8/64 ,  A61K8/676 ,  A61K9/0014 ,  A61K9/0048 ,  A61K9/08 ,  A61K31/045 ,  A61K31/12 ,  A61K31/122 ,  A61K31/375 ,  A61K31/506 ,  A61K31/7034 ,  A61K45/06 ,  A61K47/10 ,  A61Q11/00 ,  A61Q15/00 ,  A61Q17/04 ,  A61Q19/08 ,  A61K2300/00

Abstract: An object of the present invention is to provide an external use composition having a novel composition that has a superior effect promoting collagen production and is able to suppress, prevent or improve wrinkles and sagging of the skin with aging.The present invention relates to an external use composition for anti-aging, comprising (A) a lipopeptide represented by the following formula (1), or a pharmaceutically acceptable salt thereof: (wherein, R1 represents a saturated aliphatic group, or aliphatic group having a single unsaturated bond, having 9 to 19 carbon atoms, and m represents 0 or 1).